Accord Healthcare, Inc. recalls Cisplatin Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications.
- Products
-
- Cisplatin Injection
- Company
- Accord Healthcare, Inc.
- Where it was sold
-
Nationwide within the United States and PR
Nationwide
- Units affected
- 11,214 vials
- About this recall
- Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38